Medyria raises CHF 3.5 M

Medyria develops sensor-tipped microcatheters that measure blood flow velocity for coronary diagnosis. It has raised CHF 3.5 million to obtain FDA clearance and prepare the US launch of PyCath.

Announced on
Round
Undisclosed round
Amount
CHF 3.5 M
Location
Winterthur, canton of Zurich
Sector
Health & medtech

Investors

The investors were not named in the announcement.

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic